JP2008526715A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526715A5
JP2008526715A5 JP2007548841A JP2007548841A JP2008526715A5 JP 2008526715 A5 JP2008526715 A5 JP 2008526715A5 JP 2007548841 A JP2007548841 A JP 2007548841A JP 2007548841 A JP2007548841 A JP 2007548841A JP 2008526715 A5 JP2008526715 A5 JP 2008526715A5
Authority
JP
Japan
Prior art keywords
alkyl
piperazin
butyl
cycloalkyl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007548841A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526715A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/050001 external-priority patent/WO2006072608A2/en
Publication of JP2008526715A publication Critical patent/JP2008526715A/ja
Publication of JP2008526715A5 publication Critical patent/JP2008526715A5/ja
Pending legal-status Critical Current

Links

JP2007548841A 2005-01-03 2006-01-02 神経精神障害の治療のためのアリールピペラジン誘導体 Pending JP2008526715A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200500004 2005-01-03
US64100605P 2005-01-04 2005-01-04
PCT/EP2006/050001 WO2006072608A2 (en) 2005-01-03 2006-01-02 Aryl piperazine derivatives for the treatment of neuropsychiatric disorders

Publications (2)

Publication Number Publication Date
JP2008526715A JP2008526715A (ja) 2008-07-24
JP2008526715A5 true JP2008526715A5 (enExample) 2009-02-19

Family

ID=36600734

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007548841A Pending JP2008526715A (ja) 2005-01-03 2006-01-02 神経精神障害の治療のためのアリールピペラジン誘導体

Country Status (7)

Country Link
US (1) US20090238761A1 (enExample)
EP (1) EP1836192A2 (enExample)
JP (1) JP2008526715A (enExample)
AU (1) AU2006204522A1 (enExample)
CA (1) CA2593266A1 (enExample)
NZ (1) NZ555491A (enExample)
WO (1) WO2006072608A2 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2903986A1 (fr) * 2006-07-21 2008-01-25 Pierre Fabre Medicament Sa Nouveaux derives chromenes ou thiochromenes carboxamides, leur procede de preparation et leurs applications en therapeutique
GB0615809D0 (en) * 2006-08-09 2006-09-20 Istituto Di Ricerche D Biolog Therapeutic compounds
AU2007306274A1 (en) * 2006-10-13 2008-04-17 Universita Degli Studi Di Siena Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders
CA2672860C (en) * 2006-12-28 2013-01-29 Abbott Laboratories Inhibitors of poly(adp-ribose)polymerase
WO2008153573A1 (en) * 2007-06-15 2008-12-18 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use
KR20100040872A (ko) * 2007-06-25 2010-04-21 뉴로젠 코포레이션 피페라지닐 옥소알킬 테트라하이드로-베타-카르볼린 및 이의 관련 유사체
EP2238125A1 (en) * 2008-02-01 2010-10-13 NeuroSearch A/S Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors
WO2010040808A1 (en) * 2008-10-10 2010-04-15 Neurosearch A/S Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors
HUE029402T2 (en) 2012-03-16 2017-02-28 Vitae Pharmaceuticals Inc Liver X receptor modulators
CN104203950B (zh) 2012-03-16 2016-08-24 生命医药公司 肝x受体调节剂
AU2013259551B2 (en) * 2012-05-09 2017-11-02 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
AU2013329097B2 (en) * 2012-10-11 2018-10-18 Southern Research Institute Urea and amide derivatives of aminoalkylpiperazines and use thereof
WO2014173903A1 (en) * 2013-04-23 2014-10-30 Laboratorios Del Dr. Esteve, S.A. PYRAZINO[1,2-a]INDOLE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS
US9598401B2 (en) 2013-07-29 2017-03-21 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof
EP3083589B1 (en) 2013-12-20 2019-12-18 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use thereof
MA41168A (fr) * 2014-12-17 2017-10-24 Acraf Nouveaux composés antibactériens
EP3244896B1 (en) * 2015-01-12 2024-06-12 Reviva Pharmaceuticals, Inc. Methods for treating pulmonary hypertension
EP3244898A4 (en) * 2015-01-12 2018-08-22 Reviva Pharmaceuticals, Inc. Methods for treating psychosis associated with parkinson's disease
HK1245081A1 (zh) * 2015-01-12 2018-08-24 雷维瓦药品公司 用於治疗阿尔茨海默病的方法
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
TN2017000485A1 (en) 2015-06-17 2019-04-12 Pfizer Tricyclic compounds and their use as phosphodiesterase inhibitors
AU2017233716B2 (en) 2016-03-14 2020-10-29 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof
US11299476B2 (en) 2016-03-14 2022-04-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof
JP7017797B2 (ja) * 2017-02-24 2022-02-09 深▲チェン▼市霊蘭生物医薬科技有限公司 新規なドーパミンｄ３受容体選択的リガンド及びびその調製方法並びに医薬使用
TW201837034A (zh) * 2017-03-13 2018-10-16 日商大日本住友製藥股份有限公司 2, 6-二取代吡啶衍生物
GB201704325D0 (en) * 2017-03-17 2017-05-03 Argonaut Therapeutics Ltd Compounds
AU2019340675B2 (en) 2018-09-11 2024-06-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Dopamine D3 receptor selective antagonists/partial agonists and uses thereof
BR112022025238A2 (pt) 2020-06-11 2023-02-14 Chdi Foundation Inc Compostos heterocíclicos e agentes de imageamento para formar imagem da proteína huntingtina

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2777849A (en) * 1954-07-23 1957-01-15 American Cyanamid Co 1, 1'-alkylenedipiperazines and methods of preparing same
US2837522A (en) * 1955-10-20 1958-06-03 American Cyanamid Co Substituted alkylenedipiperazines
US3646047A (en) * 1970-02-02 1972-02-29 American Cyanamid Co Certain benzo(b)thiophene-2-carboxamide derivatives
US3734915A (en) * 1970-02-02 1973-05-22 American Cyanamid Co N-(-(4-phenyl-1-piperazinyl)alkyl)benzo(b)thiophene or benzofuran-2-carboxamides
FR2187311B1 (enExample) * 1972-06-02 1975-06-20 Bouchara Emile
US4803203A (en) * 1986-11-05 1989-02-07 Warner-Lambert Company Phenyl and heterocyclic piperazinyl alkoxy-benzheterocyclic compounds as antipsychotic agents
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
DE3923675A1 (de) * 1989-07-18 1991-01-24 Basf Ag Amonoalkylsubstituierte 2-aminothiazole und diese enthaltende therapeutische mittel
FR2655988B1 (fr) * 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ES2027898A6 (es) * 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
GB9306578D0 (en) * 1993-03-30 1993-05-26 Merck Sharp & Dohme Therapeutic agents
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US6100255A (en) * 1998-10-28 2000-08-08 Neurogen Corporation 3-aminoalkylamino-2H-1,4-benzoxazines and 3-aminoalkylamino-2H-1,4-benzothiazines: dopamine receptor subtype specific ligands
JP4549452B2 (ja) * 1997-12-12 2010-09-22 富山化学工業株式会社 アルキルエーテル誘導体またはその塩並びにそれらを含有するカルシウム拮抗剤
CA2351860A1 (en) * 1998-12-17 2000-06-22 Wyeth Piperazine ethylamide derivatives with 5-ht1a receptor activity
JP2003519223A (ja) * 1999-12-30 2003-06-17 ハー・ルンドベック・アクチエゼルスカベット フェニルピペラジニル誘導体
HUP0103987A3 (en) * 2001-09-28 2004-11-29 Richter Gedeon Vegyeszet Phenylpiperazinylalkyl carboxylic acid amid derivatives, process for their preparation, pharmaceutical compositions containing them and their intermediates
EP1519726B1 (de) * 2002-07-04 2007-02-21 Schwarz Pharma Ag Heteroarencarboxamide zur verwendung als dopamin-d3 liganden zur behandlung von zns-erkrankungen
WO2004024878A2 (en) 2002-09-14 2004-03-25 Gov't Of The U.S.A. As Represented By The Secretary Of The Department Of Health And Human Services Structurally rigid dopamine d3 receptor selective ligands and process for making them
DE10248067A1 (de) * 2002-10-07 2004-04-15 Proteosys Ag Heteroarylpropyl-Piperazine und Heteroarylpropyl-Piperidine
EP1658077A4 (en) * 2003-06-19 2007-06-06 Psychiatric Genomics Inc CONNECTIONS WITH DOUBLE FUNCTION AND ITS USES
FR2878524B1 (fr) * 2004-12-01 2007-01-19 Bioprojet Soc Civ Ile Nouveaux derives d'arylpiperazine

Similar Documents

Publication Publication Date Title
JP2008526715A5 (enExample)
JP2008526715A (ja) 神経精神障害の治療のためのアリールピペラジン誘導体
RU2404163C2 (ru) Производные 2,3,4,9-тетрагидро-1h-карбазола в качестве антагонистов рецептора crth2
JP5654559B2 (ja) キナゾリンジオン誘導体の治療での使用
JP2013520407A5 (enExample)
JP2001524116A (ja) ５ｈｔ１ａ、５ｈｔ１ｂおよび５ｈｔ１ｄ受容体アンタゴニスト活性を合わせ持つインドール誘導体
CN101263130A (zh) 2-苯胺-4-芳基取代的噻唑衍生物
US7858640B2 (en) Quinolines and their therapeutic use
NZ597107A (en) Heterocyclic compounds for the treatment of neurological and psychological disorders
HRP20160096T1 (hr) Supstituirani derivati izokinolina
CA2493245A1 (en) Novel quinuclidine derivatives and their use
Kumari et al. Synthesis and biological potentials of quinoline analogues: A review of literature
EP1723134A2 (en) Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
ATE231394T1 (de) Heterozyklische piperazinyl verbindungen zur behandlung von demenz
JP2012506848A5 (enExample)
JP2007522235A5 (enExample)
TW201425307A (zh) 作為激酶抑制劑之胺基－喹啉類
ZA200504675B (en) Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor
US5268378A (en) Dioxo-tetrahydroquinoline derivatives
JP2008543782A (ja) ５−ｈｔ１ａ受容体のピペラジン−ピペリジンアンタゴニストおよびアゴニスト
ES2263039T3 (es) Derivados de imidazoquinolina como ligandos del receptor a3 de adenosina.
US20040209870A1 (en) Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds
JP3117725B2 (ja) カイニン酸神経細胞毒性阻害剤及びピリドチアジン誘導体
RU2014123352A (ru) Гетероциклические карбоксамиды, полезные в качестве ингибиторов фосфодиэстеразы типа 10а
JPWO1997017970A1 (ja) カイニン酸神経細胞毒性阻害剤及びピリドチアジン誘導体